Estimation of the Power of the Food Effect on QTc to Show Assay Sensitivity
Author:
Affiliation:
1. Statistik Georg Ferber GmbH; Riehen Switzerland
2. Richmond Pharmacology Ltd; London UK
3. St Georges, University of London; London UK
Funder
Richmond Pharmacology Ltd.
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.975/fullpdf
Reference22 articles.
1. ICH E14 Questions & Answers (R3) December 10 2 http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Q_As_R3__Step4.pdf 2015
2. Implications of the IQ-CSRC prospective study: time to revise ICH E14;Darpo;Drug Saf,2015
3. Can bias evaluation provide protection against false-negative results in QT studies without a positive control using exposure-response analysis?;Ferber;J Clin Pharmacol,2017
4. Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study;Shah;Eur J Clin Pharmacol,2015
5. Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist;Shah;Eur J Clin Pharmacol,2016
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Application of Trial Simulation in the Design of a Prospective Study for Concentration-QTc Analysis in Support of a Thorough QT Study Waiver;The AAPS Journal;2020-08-02
2. PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration;Journal of Pharmacokinetics and Pharmacodynamics;2020-06-22
3. Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development Programs;Therapeutic Innovation & Regulatory Science;2020-01
4. QT Assessment in Early Drug Development: The Long and the Short of It;International Journal of Molecular Sciences;2019-03-15
5. Efficient Design of Integrated and Adaptively Interlinked Protocols for Early-Phase Drug Development Programs;Therapeutic Innovation & Regulatory Science;2019-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3